B. Riley Lifts Spectrum Pharmaceuticals' Price Target to $1.14 From $1 on Heels of Announced Sale to Assertio Holdings, Keeps Neutral Rating
B. Riley Lifts Spectrum Pharmaceuticals' Price Target to $1.14 From $1 on Heels of Announced Sale to Assertio Holdings, Keeps Neutral Rating
在宣佈出售給Assertio Holdings之後，B. Riley將Spectrum Pharmicals的目標股價從1美元上調至1.14美元，維持中性評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊